Search Results - "Tojikubo, Masayuki"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Development of type 1 diabetes in a patient treated with anti‐interleukin‐6 receptor antibody for rheumatoid arthritis by Kawasaki, Eiji, Fukuyama, Takahiro, Uchida, Aira, Sagara, Yoko, Nakano, Yuko, Tamai, Hidekazu, Tojikubo, Masayuki, Hiromatsu, Yuji, Koga, Nobuhiko

    Published in Journal of diabetes investigation (01-04-2022)
    “…Interleukin‐6 is a pleiotropic cytokine that plays a pathogenic role in type 1 diabetes. Therefore, anti‐interleukin‐6 receptor antibody, tocilizumab, used for…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Different effects of linagliptin and sitagliptin on blood pressure and renal function in Japanese patients with type 2 diabetes mellitus by Tojikubo, Masayuki, Tajiri, Yuji

    Published in Diabetology international (01-11-2017)
    “…Aims To compare and evaluate effects of two DPP-4 inhibitors with different excretion routes on systemic and renal hemodynamics in Japanese patients with type…”
    Get full text
    Journal Article
  4. 4

    Statin‐induced autoimmune hepatitis in patients with type 1 diabetes: A report of two cases and literature review by Kawasaki, Eiji, Fukuyama, Takahiro, Kuriyama, Erisa, Uchida, Aira, Sagara, Yoko, Tamai, Hidekazu, Nakano, Yuko, Tojikubo, Masayuki, Koga, Nobuhiko

    Published in Journal of diabetes investigation (01-11-2020)
    “…Statins are widely used medications for the treatment of hypercholesterolemia, as well as prevention of cardiovascular disease. We report two patients with…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Long-term efficacy of sitagliptin for the treatment of type 2 diabetic patients in Japan by Tajiri, Yuji, Tsuruta, Munehisa, Ohki, Tsuyoshi, Kato, Tomoko, Sasaki, Yuko, Tanaka, Kayo, Kono, Shusuke, Tojikubo, Masayuki, Yamada, Kentaro

    Published in ENDOCRINE JOURNAL (2012)
    “…We studied the efficacy of sitagliptin in type 2 diabetic patients of our outpatient clinics. Since December in 2009, 164 patients have been treated by…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A case of isolated hypocalciuric hypercalcemia and type 2 diabetes mellitus followed by Grave’s disease by Tojikubo, Masayuki, Akazawa, Shoichi, Nakano, Yuko, Nakamura, Satoe, Yamashita, Shunichi

    Published in Acta Medica Nagasakiensia (01-07-2014)
    “…A 73-year-old woman was found to have diabetes mellitus along with elevated levels of calcium and alkaline phosphatase.She had also sometimes exhibited slight…”
    Get full text
    Journal Article
  9. 9

    Enzyme-linked immunosorbent assay of 3 Screen Islet Cell Autoantibody in patients with autoimmune thyroid disease by Kawasaki, Eiji, Tamai, Hidekazu, Fukuyama, Takahiro, Sagara, Yoko, Hidaka, Ryutaro, Uchida, Aira, Tojikubo, Masayuki, Tatsumoto, Narihito, Akehi, Yuko, Hiromatsu, Yuji

    Published in World journal of diabetes (15-05-2024)
    “…In recent years, the emergence of multiplex technology that can simultaneously measure multiple anti-islet autoantibodies has become particularly valuable for…”
    Get full text
    Journal Article
  10. 10

    Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes by Kawasaki, Eiji, Nakano, Yuko, Fukuyama, Takahiro, Uchida, Aira, Sagara, Yoko, Tamai, Hidekazu, Tojikubo, Masayuki, Hiromatsu, Yuji, Koga, Nobuhiko

    Published in World journal of diabetes (15-12-2021)
    “…Omarigliptin is one of several once-weekly dipeptidyl peptidase-4 inhibitors (DPP-4is). Despite the high frequency of switching from various daily DPP-4is to…”
    Get full text
    Journal Article
  11. 11

    Characterization of patients with diabetes who were incidentally found to be GAD autoantibody-positive by bridging-type enzyme-linked immunosorbent assay by Kawasaki, Eiji, Fukuyama, Takahiro, Uchida, Aira, Sagara, Yoko, Tamai, Hidekazu, Nakano, Yuko, Tojikubo, Masayuki, Hiromatsu, Yuji, Koga, Nobuhiko

    Published in Journal of diabetes investigation (29-05-2020)
    “…This study aimed to characterize diabetic patients incidentally found to be positive for glutamic acid decarboxylase autoantibodies (GADA) in general practice…”
    Get full text
    Journal Article
  12. 12

    Development of Lobular Panniculitis Long After Completing the Personalized Peptide Vaccine Therapy by Uchida, Aira, Kawasaki, Eiji, Tojikubo, Masayuki, Tamai, Hidekazu, Sagara, Yoko, Nakano, Yuko, Uji, Yoshitaka, Masuda, Masanori, Yamaguchi, Takahiro, Yutani, Shigeru

    Published in The American journal of case reports (27-12-2018)
    “…BACKGROUND Personalized peptide vaccine therapy is regarded as a well-tolerated, safe and effective immunotherapy for patients with advanced cancers. Herein we…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15